420 related articles for article (PubMed ID: 15955597)
1. Distinct signaling pathways for induction of type II NOS by IFNgamma and LPS in BV-2 microglial cells.
Shen S; Yu S; Binek J; Chalimoniuk M; Zhang X; Lo SC; Hannink M; Wu J; Fritsche K; Donato R; Sun GY
Neurochem Int; 2005 Sep; 47(4):298-307. PubMed ID: 15955597
[TBL] [Abstract][Full Text] [Related]
2. Signaling mechanisms of interferon gamma induced apoptosis in chromaffin cells: involvement of nNOS, iNOS, and NFkappaB.
Pérez-Rodríguez R; Roncero C; Oliván AM; González MP; Oset-Gasque MJ
J Neurochem; 2009 Feb; 108(4):1083-96. PubMed ID: 19141072
[TBL] [Abstract][Full Text] [Related]
3. Synergistic expression of inducible nitric oxide synthase by phorbol ester and interferon-gamma is mediated through NF-kappaB and ERK in microglial cells.
Han IO; Kim HS; Kim HC; Joe EH; Kim WK
J Neurosci Res; 2003 Sep; 73(5):659-69. PubMed ID: 12929133
[TBL] [Abstract][Full Text] [Related]
4. LPS-induced iNOS expression in Bv-2 cells is suppressed by an oxidative mechanism acting on the JNK pathway--a potential role for neuroprotection.
Svensson C; Fernaeus SZ; Part K; Reis K; Land T
Brain Res; 2010 Mar; 1322():1-7. PubMed ID: 20138851
[TBL] [Abstract][Full Text] [Related]
5. IL-1beta, an immediate early protein secreted by activated microglia, induces iNOS/NO in C6 astrocytoma cells through p38 MAPK and NF-kappaB pathways.
Kim YJ; Hwang SY; Oh ES; Oh S; Han IO
J Neurosci Res; 2006 Oct; 84(5):1037-46. PubMed ID: 16881054
[TBL] [Abstract][Full Text] [Related]
6. Withaferin A inhibits iNOS expression and nitric oxide production by Akt inactivation and down-regulating LPS-induced activity of NF-kappaB in RAW 264.7 cells.
Oh JH; Lee TJ; Park JW; Kwon TK
Eur J Pharmacol; 2008 Dec; 599(1-3):11-7. PubMed ID: 18838070
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of lipopolysaccharide-stimulated NO production by a novel synthetic compound CYL-4d in RAW 264.7 macrophages involving the blockade of MEK4/JNK/AP-1 pathway.
Lin MW; Tsao LT; Chang LC; Chen YL; Huang LJ; Kuo SC; Tzeng CC; Lee MR; Wang JP
Biochem Pharmacol; 2007 Jun; 73(11):1796-806. PubMed ID: 17379190
[TBL] [Abstract][Full Text] [Related]
8. Excretory-secretory products from Paragonimus westermani increase nitric oxide production in microglia in PKC-dependent and -independent manners.
Jin Y; Choi IY; Kim C; Hong S; Kim WK
Neurosci Res; 2009 Oct; 65(2):141-7. PubMed ID: 19539668
[TBL] [Abstract][Full Text] [Related]
9. Antisense oligonucleotides targeting protein kinase C-alpha, -beta I, or -delta but not -eta inhibit lipopolysaccharide-induced nitric oxide synthase expression in RAW 264.7 macrophages: involvement of a nuclear factor kappa B-dependent mechanism.
Chen CC; Wang JK; Lin SB
J Immunol; 1998 Dec; 161(11):6206-14. PubMed ID: 9834107
[TBL] [Abstract][Full Text] [Related]
10. Effect of rottlerin, a PKC-delta inhibitor, on TLR-4-dependent activation of murine microglia.
Kim DC; Kim SH; Jeong MW; Baek NI; Kim KT
Biochem Biophys Res Commun; 2005 Nov; 337(1):110-5. PubMed ID: 16182255
[TBL] [Abstract][Full Text] [Related]
11. Signal transduction pathways regulating cyclooxygenase-2 in lipopolysaccharide-activated primary rat microglia.
Akundi RS; Candelario-Jalil E; Hess S; Hüll M; Lieb K; Gebicke-Haerter PJ; Fiebich BL
Glia; 2005 Aug; 51(3):199-208. PubMed ID: 15800925
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of nitric oxide production by the carbazole compound LCY-2-CHO via blockade of activator protein-1 and CCAAT/enhancer-binding protein activation in microglia.
Chang LC; Tsao LT; Chang CS; Chen CJ; Huang LJ; Kuo SC; Lin RH; Wang JP
Biochem Pharmacol; 2008 Aug; 76(4):507-19. PubMed ID: 18586011
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of fucoidan on nitric oxide production in lipopolysaccharide-activated primary microglia.
Cui YQ; Zhang LJ; Zhang T; Luo DZ; Jia YJ; Guo ZX; Zhang QB; Wang X; Wang XM
Clin Exp Pharmacol Physiol; 2010 Apr; 37(4):422-8. PubMed ID: 19843098
[TBL] [Abstract][Full Text] [Related]
14. Signal transduction pathways of nitric oxide release in primary microglial culture challenged with gram-positive bacterial constituent, lipoteichoic acid.
Chien HF; Yeh KY; Jiang-Shieh YF; Wei IH; Chang CY; Chang ML; Wu CH
Neuroscience; 2005; 133(2):423-36. PubMed ID: 15878805
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of inducible nitric-oxide synthase expression by (5R)-5-hydroxytriptolide in interferon-gamma- and bacterial lipopolysaccharide-stimulated macrophages.
Zhou R; Zheng SX; Tang W; He PL; Li XY; Yang YF; Li YC; Geng JG; Zuo JP
J Pharmacol Exp Ther; 2006 Jan; 316(1):121-8. PubMed ID: 16166270
[TBL] [Abstract][Full Text] [Related]
16. Insoluble matrix components of glioma cells suppress LPS-mediated iNOS/NO induction in microglia.
Kim YJ; Hwang SY; Han IO
Biochem Biophys Res Commun; 2006 Sep; 347(3):731-8. PubMed ID: 16843440
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of lipopolysaccharide-induced microglial activation by preexposure to neurotrophin-3.
Tzeng SF; Huang HY; Lee TI; Jwo JK
J Neurosci Res; 2005 Sep; 81(5):666-76. PubMed ID: 16015620
[TBL] [Abstract][Full Text] [Related]
18. Involvement of protein kinase C and not of NF kappa B in the modulation of macrophage nitric oxide synthase by tumor-derived phosphatidyl serine.
Calderon CL; Torroella-Kouri M; Dinapoli MR; Lopez DM
Int J Oncol; 2008 Mar; 32(3):713-21. PubMed ID: 18292949
[TBL] [Abstract][Full Text] [Related]
19. Redox regulation of glial inflammatory response to lipopolysaccharide and interferongamma.
Pawate S; Shen Q; Fan F; Bhat NR
J Neurosci Res; 2004 Aug; 77(4):540-51. PubMed ID: 15264224
[TBL] [Abstract][Full Text] [Related]
20. Blockade of IL-15 activity inhibits microglial activation through the NFkappaB, p38, and ERK1/2 pathways, reducing cytokine and chemokine release.
Gomez-Nicola D; Valle-Argos B; Nieto-Sampedro M
Glia; 2010 Feb; 58(3):264-76. PubMed ID: 19610094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
